Hormone therapy shows promise in preventing relapse in postpartum meth users
NCT ID NCT05128071
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase study tested whether a hormone called progesterone could help new mothers avoid returning to methamphetamine use after childbirth. 34 postpartum women with a history of meth use but currently abstinent took either progesterone or a placebo for 12 weeks. The goal was to see if the treatment was safe, feasible, and could reduce cravings and prevent relapse.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METHAMPHETAMINE USE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Utah
Salt Lake City, Utah, 84132, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a psychedelic help break meth addiction in people with HIV?
- Weight-Loss drug may curb stimulant cravings, brain scans suggest
- Could an antidepressant help curb meth use in people treated for opioid addiction?
- Meth reduction may lower STI risk, small study suggests
- Could ketamine therapy help people quit meth?
- Study reveals Meth's impact on hidden HIV